Indian Army Department of Military Affairs Tender for Medical & Pharmaceutical Supplies 2026 – 5 ml Vials, Hepatitis B Vaccine, Antiseptics and Topical Solutions

Bidders must confirm eligibility for defense procurement, prepare GST, PAN, and financial statements, obtain OEM authorizations, and submit a complete technical bid with product certifications. Ensure the bid includes the 25% quantity option details and delivery plan aligned with the last order date.

Required submissions typically include GST certificate, PAN card, experience certificates, financial statements, EMD proof, technical compliance certificates, OEM authorizations, and any product-specific certifications for vaccines and topical solutions as per buyer terms.

The scope is goods-only supply for 8 items, including tetanus toxoid vials, Hepatitis B vaccine, rapid PAP stain, analgesic and anti-inflammatory creams, antiseptics, antispasmodics, and mupirocin ointment, with all costs included in the bid price.

The option clause allows up to a 25% quantity variation at contract placement and during currency, with delivery time extended proportionally based on the formula in the tender, minimum 30 days.

The estimated value is ₹514,401.6, signaling a moderate-scale procurement with potential quantity adjustments under the option clause during contract execution.

The tender data does not specify standards; bidders should seek clarification but should be prepared with vaccine-quality certifications and manufacturer approvals where applicable, along with IS or BIS marks if mandated by the buyer.

Delivery timing is governed by the last date of the original delivery order; any extension occurs through the option clause with extended period calculated per quantity variation formula, ensuring a minimum 30 days for additional time.

Payment terms are not explicitly stated in the data; bidders should confirm whether payment follows milestones, advance payment requirements, or post-delivery settlement during bid clarifications.